ZA969147B - Application of the gax protein to the treatment of cancer - Google Patents
Application of the gax protein to the treatment of cancerInfo
- Publication number
- ZA969147B ZA969147B ZA969147A ZA969147A ZA969147B ZA 969147 B ZA969147 B ZA 969147B ZA 969147 A ZA969147 A ZA 969147A ZA 969147 A ZA969147 A ZA 969147A ZA 969147 B ZA969147 B ZA 969147B
- Authority
- ZA
- South Africa
- Prior art keywords
- cancer
- treatment
- application
- gax protein
- gax
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/10—Vectors comprising a non-peptidic targeting moiety
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9512871A FR2740344B1 (fr) | 1995-10-31 | 1995-10-31 | Application de la proteine gax au traitement de cancers |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA969147B true ZA969147B (en) | 1997-05-27 |
Family
ID=9484112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA969147A ZA969147B (en) | 1995-10-31 | 1996-10-30 | Application of the gax protein to the treatment of cancer |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0858466A1 (xx) |
JP (1) | JPH11514881A (xx) |
KR (1) | KR19990067174A (xx) |
AU (1) | AU730324B2 (xx) |
BR (1) | BR9611206A (xx) |
CA (1) | CA2233250A1 (xx) |
CZ (1) | CZ131598A3 (xx) |
FR (1) | FR2740344B1 (xx) |
HU (1) | HUP9900011A3 (xx) |
NO (1) | NO981822D0 (xx) |
SK (1) | SK56198A3 (xx) |
WO (1) | WO1997016459A1 (xx) |
ZA (1) | ZA969147B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2754822B1 (fr) * | 1996-10-18 | 1998-11-27 | Rhone Poulenc Rorer Sa | Polypeptides comprenant des domaines de la proteine gax, impliques dans la repression de transcription et/ou interagissant avec d'autres proteines, acides nucleiques correspondants et leurs utilisations |
WO2002000241A2 (en) * | 2000-06-28 | 2002-01-03 | Aventis Pharma S.A. | Compositions and methods for regulating the cell cycle using a ki gene or polypeptide |
JP5309159B2 (ja) | 2008-01-09 | 2013-10-09 | コングク ユニバーシティ インダストリアル コーオペレーション コーポレーション | バキュロウイルスを利用したワクチン |
KR101230913B1 (ko) | 2009-11-06 | 2013-02-07 | 중앙대학교 산학협력단 | 나노입자-기반된 유전자 운반체 |
KR101232123B1 (ko) | 2010-10-08 | 2013-02-12 | 연세대학교 산학협력단 | 재조합된 유전자발현 조절서열을 가지는 종양 특이적 발현이 개선된 유전자 전달체 |
EP2784155B1 (en) | 2011-11-24 | 2018-06-13 | Viromed Co. Ltd. | Adenovirus producing novel cell line and the use thereof |
KR101429696B1 (ko) | 2012-11-21 | 2014-08-13 | 국립암센터 | 안전성 및 항암활성이 증가된 재조합 아데노바이러스 및 이의 용도 |
WO2017065497A1 (ko) | 2015-10-12 | 2017-04-20 | 한양대학교 산학협력단 | 유전자 전달 및 유전자 치료를 위한 아데노바이러스 복합체 |
WO2019117632A1 (ko) | 2017-12-13 | 2019-06-20 | 한양대학교 산학협력단 | 재조합 아데노바이러스 및 이를 포함하는 줄기세포 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2705361B1 (fr) * | 1993-05-18 | 1995-08-04 | Centre Nat Rech Scient | Vecteurs viraux et utilisation en thérapie génique. |
US5856121A (en) * | 1994-02-24 | 1999-01-05 | Case Western Reserve University | Growth arrest homebox gene |
FR2732357B1 (fr) * | 1995-03-31 | 1997-04-30 | Rhone Poulenc Rorer Sa | Vecteurs viraux et utilisation pour le traitement des desordres hyperproliferatifs, notamment de la restenose |
-
1995
- 1995-10-31 FR FR9512871A patent/FR2740344B1/fr not_active Expired - Fee Related
-
1996
- 1996-10-28 AU AU74982/96A patent/AU730324B2/en not_active Ceased
- 1996-10-28 BR BR9611206A patent/BR9611206A/pt not_active Application Discontinuation
- 1996-10-28 HU HU9900011A patent/HUP9900011A3/hu unknown
- 1996-10-28 CZ CZ981315A patent/CZ131598A3/cs unknown
- 1996-10-28 KR KR1019980703125A patent/KR19990067174A/ko not_active Application Discontinuation
- 1996-10-28 WO PCT/FR1996/001690 patent/WO1997016459A1/fr not_active Application Discontinuation
- 1996-10-28 SK SK561-98A patent/SK56198A3/sk unknown
- 1996-10-28 CA CA002233250A patent/CA2233250A1/fr not_active Abandoned
- 1996-10-28 EP EP96937351A patent/EP0858466A1/fr not_active Withdrawn
- 1996-10-28 JP JP9517110A patent/JPH11514881A/ja active Pending
- 1996-10-30 ZA ZA969147A patent/ZA969147B/xx unknown
-
1998
- 1998-04-23 NO NO981822A patent/NO981822D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FR2740344B1 (fr) | 1997-11-21 |
CZ131598A3 (cs) | 1998-08-12 |
WO1997016459A1 (fr) | 1997-05-09 |
JPH11514881A (ja) | 1999-12-21 |
NO981822L (no) | 1998-04-23 |
AU7498296A (en) | 1997-05-22 |
AU730324B2 (en) | 2001-03-01 |
FR2740344A1 (fr) | 1997-04-30 |
SK56198A3 (en) | 1998-11-04 |
BR9611206A (pt) | 1999-03-30 |
HUP9900011A2 (hu) | 1999-04-28 |
CA2233250A1 (fr) | 1997-05-09 |
NO981822D0 (no) | 1998-04-23 |
HUP9900011A3 (en) | 1999-11-29 |
EP0858466A1 (fr) | 1998-08-19 |
KR19990067174A (ko) | 1999-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA96740B (en) | Skin treatment composition | |
GB9310241D0 (en) | Cosmetic treatment of substrates | |
HU9603369D0 (en) | Treatment of vegetables | |
AU7905894A (en) | Treatment of poultry | |
AUPM761094A0 (en) | Treatment of hides | |
ZA969147B (en) | Application of the gax protein to the treatment of cancer | |
PL336760A1 (en) | Treatment of skin diseases | |
AU4202096A (en) | The use of sertraline to treat cancer patients | |
AU7565894A (en) | Acupuncture treatment of common baldness | |
AU6829696A (en) | Treatment of solutions | |
AU4417996A (en) | Treatment of prostate cancer | |
AU6171196A (en) | Therapeutic uses of ta99 | |
GB9400600D0 (en) | Treatment of motion seckness | |
GB2331014B (en) | Therapeutic uses of glucan | |
IL117365A0 (en) | Treatment of eczema | |
AU3247995A (en) | Treatment of hides | |
EP0705104A4 (en) | ANTI-CANCER THERAPY | |
AUPO955497A0 (en) | Treatment of cancer | |
GB9503200D0 (en) | Methods of treatment | |
AU2375297A (en) | Treatment of hides | |
AUPO598197A0 (en) | Treatment of hides | |
GB9507482D0 (en) | Skin treatment composition | |
GB9717401D0 (en) | Treatment of psoriasis | |
GB9710054D0 (en) | Treatment of diseases | |
GB9226032D0 (en) | Treatment of cancer |